[Treatment of acute leukemias in adults. II. Preliminary analysis of the treatment results according to AR and RAMP programs].
Thirty patients with acute non-lymphoblastic leukaemia were treated. They were randomly assigned to treatment according to programme AR (14 patients) and RAMP (16 patients). The groups were comparable for age and haematological state. Complete remission was obtained in 7 patients out of 14 treated by the AR programme and 6 out of 16 treated by the RAMP programme. The median duration of complete remission is as yet 15 weeks and 16 weeks respectively. The toxic side effects during treatment by the AR programme was statistically significantly higher than in the treatment by the RAMP programme. In the first group 42.8% of early deaths occurred, while in the second group 6.2% patients died early.
D000208:Acute Disease; D000328:Adult; D003561:Cytarabine / Q000008:administration & dosage* / Q000633:toxicity; D003630:Daunorubicin / Q000008:administration & dosage* / Q000633:toxicity; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007938:Leukemia / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D003561:Cytarabine; D003630:Daunorubicin
Leczenie ostrych białaczek u dorosłych. II. Wstepna analiza wyników leczenia wg programów AR i RAMP.